Advertisement
Table 6 Time loss due to colorectal cancer diagnosis and treatment
| Characteristic | Time loss (person-days)a | Statisticsb | P b | ||
|---|---|---|---|---|---|
| Overall | Patients | Caregivers | |||
| Total | 95.9 | 54.0 | 41.9 | – | – |
| Hospital type | |||||
| General | 40.0 | 38.7 | 78.6 | −4.10 | <0.001 |
| Specialized | 59.9 | 43.3 | 103.2 | ||
| Age at diagnosis (years) | |||||
| <45 | 103.5 | 61.7 | 41.7 | 0.76 | 0.516 |
| 45–54 | 98.3 | 55.6 | 42.7 | ||
| 55–64 | 95.4 | 53.6 | 41.8 | ||
| ≥65 | 90.7 | 49.0 | 41.6 | ||
| Sex | |||||
| Men | 98.8 | 55.7 | 43.1 | 1.31 | 0.191 |
| Women | 92.2 | 51.8 | 40.3 | ||
| Education | |||||
| Primary school or below | 95.4 | 53.7 | 41.7 | 1.84 | 0.138 |
| Junior high school | 94.9 | 54.3 | 40.6 | ||
| Senior high school | 95.2 | 52.0 | 43.2 | ||
| Undergraduate or higher | 102.6 | 58.7 | 43.9 | ||
| Occupation | |||||
| Farmer | 101.1 | 58.1 | 43.0 | 4.80 | <0.001 |
| Enterprise or company employee/worker | 98.8 | 53.7 | 45.1 | ||
| Self-employee or unemployee ununemployee | 78.8 | 45.8 | 33.0 | ||
| Retiree | 93.5 | 52.7 | 40.8 | ||
| Public sector employee | 98.6 | 53.8 | 44.8 | ||
| Others | 96.5 | 52.9 | 43.6 | ||
| Healthcare insurance type | |||||
| Urban employee basic medical insurance | 99.7 | 54.6 | 45.0 | 3.64 | 0.003 |
| Urban resident basic medical insurance | 82.2 | 43.3 | 38.9 | ||
| New rural cooperative medical scheme | 99.3 | 58.8 | 40.4 | ||
| Commercial insurance | 87.0 | 60.4 | 26.5 | ||
| Self-paid | 85.0 | 46.2 | 38.8 | ||
| Other | 127.0 | 65.0 | 62.0 | ||
| Previous-year household income (CNY) | |||||
| <20,000 | 98.1 | 56.1 | 42.0 | 1.48 | 0.219 |
| 20,000–39,999 | 99.3 | 57.3 | 42.0 | ||
| 40,000–69,999 | 96.7 | 54.5 | 42.2 | ||
| ≥70,000 | 92.1 | 50.3 | 41.8 | ||
| Clinical stage | |||||
| I | 76.1 | 40.1 | 36.0 | 16.05 | <0.001 |
| II | 77.4 | 42.8 | 34.6 | ||
| III | 98.0 | 55.6 | 42.4 | ||
| IV | 126.8 | 73.7 | 53.1 | ||
| Pathologic type | |||||
| Adenocarcinoma | 97.0 | 55.0 | 42.0 | 2.25 | 0.026 |
| Others | 82.4 | 46.6 | 35.8 | ||
| Therapeutic regimen | |||||
| Surgery | 70.6 | 39.9 | 30.7 | 18.28 | <0.001 |
| Chemotherapy | 115.7 | 66.1 | 49.6 | ||
| Surgery and postoperative chemotherapy | 98.2 | 55.8 | 42.5 | ||
| Symptomatic treatment | 93.3 | 49.2 | 44.1 | ||
| Concurrent chemoradiotherapy | 196.2 | 103.0 | 93.2 | ||
| Radiotherapy | 188.0 | 105.1 | 82.9 | ||
| Neoadjuvant chemotherapy and surgery | 91.8 | 53.7 | 38.1 | ||
